Duodenal Fluid-Based Biomarker study
- Conditions
- Neoplasms
- Registration Number
- KCT0009675
- Lead Sponsor
- Asan Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 122
Among study subjects requiring gastro-duodenal endoscopy or endoscopic ultrasound or endoscopic retrograde biliary pancreatic angiography for medical purposes
Pancreatic cancer should be in both 1 and 2, 3 or 4.
The control group, which is not pancreatic cancer, should be in both 1 and 2, 5 or 6.
?Be at least 19 years old
?Receipt of consent for gastro-duodenal endoscopy or endoscopic ultrasound or endoscopic retrograde biliary pancreatic procedure prior to duodenal fluid inhalation patient
?Biopsy proven pancreatic ductal adenocarcinoma (PDAC) with stage I-IV
?Suspected pancreatic cancer on imaging and scheduled for endoscopic ultrasound-guided pancreatic biopsy patient
?Patient with pancreatic cystic tumors or patient with pancreatitis (acute or chronic)
?No pancreatic disease patient
Pancreatic cancer and non-pancreatic cancer control groups must not meet all of the items 1 to 3 to be eligible for enrollment.
?Hemodynamically unstable for endoscopy to be performed
?If there is a large amount of ascites that is not controlled to perform endoscopy
?If you have a coagulation disorder that cannot be corrected for endoscopy
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method